Detailseite
Projekt Druckansicht

The role of the endocannabinoid system in the regulation of cellular immune responses in the skin

Fachliche Zuordnung Biologische Psychiatrie
Förderung Förderung von 2008 bis 2016
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 42860621
 
Erstellungsjahr 2017

Zusammenfassung der Projektergebnisse

G-protein coupled cannabinoid receptors (CB1 and CB2), endogenous lipid ligands (endocannabinoids) and the enzymatic machinery involved in their synthesis and degradation constitute the “endocannabinoid system” (ECS). Using pharmacological and genetic approaches to block CB receptor signaling, we demonstrated that the ECS attenuates allergic inflammation in experimental models for contact allergy and atopic dermatitis. In particular, our observations reveal a previously unrecognized physiological role of CB1 receptors on keratinocytes for the maintenance of epidermal integrity and permeability barrier functions by endocannabinoids which contributes to the protection against contact allergic inflammation. These findings could open up new strategies for the topical treatment of inflammatory skin diseases with the help of antiinflammatory lipids, including cannabinoids.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung